Pharmafile Logo

SCM Pharma

SCM Pharma is a contract development & manufacturing organisation (CDMO) that develops and makes novel, difficult and dangerous drugs on behalf of our clients. Our formulation development, cGMP manufacturing and aseptic processing services include the sterile filling of liquids, gels and powders (including flammable products) into a range of final dosage forms including ampoules, vials, cartridges, syringes and bottles. So if you’re a pharmaceutical, biotech, medical device or healthcare institution in need of formulation development, clinical manufacturing or contract filling involving a complex product or process – let’s talk.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

Unit 6 Regents Drive, Low Prudhoe Industrial Estate, Prudhoe, Northumberland, NE42 6PX, United Kingdom
+44(0) 1661 833 693

 Latest Content from PMHub 

Cholangiocarcinoma – Disease Awareness

BackgroundCholangiocarcinoma (CCA) is a rare type of bile duct cancer, and it’s the second most common primary liver cancer in the world. Unfortunately, patients with CCA historically have limited treatment...

Health content that resonates

Videos and Podcasts | November 7, 2022 | Thrive Agency

Here at Thrive, our purpose is to help everyone to better health through content that informs and empowers them.Since 2001 our researchers, writers, medical and behavioural experts have been on...

How Pharma, Payers, & Providers are Leveraging Patient Self-Management Platforms

Rick Anderson, President of DarioHealth, explores digital therapeutics, how DarioHealth is utilizing AI and behavioral science to personalize each user’s health journey, and how this approach can help improve diversity...

The fast-paced future of cell and gene therapies

In this report, we interview patients, researchers, and biopharmaceutical leaders to explore the complex landscape for the development of cell and gene therapies and share commercial recommendations from our specialist...

Personalized Oncology: Calling for a New Kind of Partnership:

White Papers and Resources | October 28, 2022 | Inizio

In the 1990s, biomarkers were the future of personalized medicine and a “lab on a chip” was the holy grail of understanding patient health. As much as past predictions of...

Expanding Opportunities for Healthcare with “Digital Twins”

Brad Womble, Senior Director of Strategy, Marketing and Mergers & Acquisitions, at Jabil Healthcare dives into several thought-provoking topics, including how insights from “digital twins” can be used to improve...

Overcoming challenges in digital pharma to get to launch quicker

Press Releases | October 27, 2022 | Graphite Digital

We take a look at why it can take pharma businesses so long to get their digital products into the hands of patients or HCPs, and what can be done...